Publications by authors named "Dido Lenze"

75Publications

H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.

Nat Commun 2020 07 20;11(1):3651. Epub 2020 Jul 20.

Charité - University Medical Center, Department of Hematology, Oncology and Tumor Immunology, Virchow Campus, and Molekulares Krebsforschungszentrum, Augustenburger Platz 1, 13353, Berlin, Germany.

View Article and Find Full Text PDF
July 2020

Support of a molecular tumour board by an evidence-based decision management system for precision oncology.

Eur J Cancer 2020 03 23;127:41-51. Epub 2020 Jan 23.

Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany; Department of Hematology and Oncology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 30, 12203 Berlin, Germany; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Straße 2, 10178, Berlin, Germany. Electronic address:

View Article and Find Full Text PDF
March 2020

DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations.

PLoS One 2019 16;14(8):e0220681. Epub 2019 Aug 16.

Department of Experimental Hematopathology, Institute of Pathology, Charité Medical University, Berlin, Berlin, Germany.

View Article and Find Full Text PDF
March 2020

DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.

Mod Pathol 2019 06 5;32(6):855-865. Epub 2019 Feb 5.

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

View Article and Find Full Text PDF
June 2019

RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.

BMC Cancer 2018 Nov 22;18(1):1158. Epub 2018 Nov 22.

Charité-Universitätsmedizin Berlin corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany.

View Article and Find Full Text PDF
November 2018

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients.

Oncotarget 2018 Apr 6;9(26):18529-18539. Epub 2018 Apr 6.

Charité-Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.

View Article and Find Full Text PDF
April 2018

Intratumoral morphological heterogeneity can be an indicator of genetic heterogeneity in colorectal cancer.

Exp Mol Pathol 2018 02 11;104(1):76-81. Epub 2018 Jan 11.

Institute of Pathology, Charité, University Medicine Berlin, Berlin, Germany.

View Article and Find Full Text PDF
February 2018

Senescence-associated reprogramming promotes cancer stemness.

Nature 2018 01 20;553(7686):96-100. Epub 2017 Dec 20.

Charité - Universitätsmedizin Berlin, Medical Department of Hematology, Oncology and Tumor Immunology, and Molekulares Krebsforschungszentrum - MKFZ, Virchow Campus, 13353 Berlin, Germany.

View Article and Find Full Text PDF
January 2018

Influence of mucinous and necrotic tissue in colorectal cancer samples on KRAS mutation analysis.

Pathol Res Pract 2017 Jun 6;213(6):606-611. Epub 2017 May 6.

Institute of Pathology, Charité, University Medicine Berlin, Germany.

View Article and Find Full Text PDF
June 2017

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

J Clin Oncol 2017 Aug 19;35(22):2515-2526. Epub 2017 May 19.

Annette M. Staiger, Heike Horn, and German Ott, Institute of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart; Annette M. Staiger and Heike Horn, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; Annette M. Staiger and Heike Horn, University of Tuebingen, Tuebingen; Marita Ziepert and Markus Löffler, Institute for Medical Informatics, Statistics and Epidemiology, Universität Leipzig, Leipzig; Thomas F.E. Barth and Peter Möller, Institute of Pathology, Universitätsklinikum Ulm, Ulm; Heinz-Wolfram Bernd and Alfred C. Feller, Haematopathologie Luebeck, Luebeck; Wolfram Klapper and Monika Szczepanowski, Institute of Pathology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel; Monika Szczepanowski, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel; Michael Hummel and Dido Lenze, Institute of Pathology, Campus Benjamin Franklin, Charité Universitätsmedizin; Harald Stein, Pathodiagnostik Berlin, Berlin; Martin-Leo Hansmann and Sylvia Hartmann, Dr. Senckenberg Institute of Pathology, Goethe University Hospital, Frankfurt; Georg Lenz, Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, and Cluster of Excellence EXC 1003, Cells in Motion, Münster; Lorenz Trümper, Georg-August Universität, Göttingen; Norbert Schmitz, Asklepios Klinik St Georg, Hamburg; Michael Pfreundschuh, Saarland University Medical School, Homburg/Saar; Andreas Rosenwald, Institute of Pathology, Universität Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany; David W. Scott, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; and Sergio Cogliatti, Institute of Pathology, Kantonal Hospital St Gallen, St Gallen, Switzerland.

View Article and Find Full Text PDF
August 2017